Product Information

FOCALIN XR 10 MG CAPSULE is a brand product labeled by Sandoz Inc., priced at $4.7619 per EA under NDC 66758023631. Its NADAC has been published 32 times since Jan 14, 2026.

FDA first approved this application on May 26, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FOCALIN XR 10 MG CAPSULE

dexmethylphenidate hydrochloride
$4.7619per EA
High Outlier
DEA Schedule CII

Strength

10 mg/1

Manufacturer

Sandoz Inc.

NDC

66758023631

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021802

FDA Approved

5/26/2005

TE Code

AB

On Market Since

5/31/2005

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for FOCALIN XR 10 MG CAPSULE has been published 32 times since Jan 14, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$4.7619 per EA
All-time high$4.7681 (May 13, 2026)
All-time low$4.7590 (May 20, 2026)
52-week high$4.7681
52-week low$4.7590
Median price$4.7681
Average price$4.7652
Largest weekly change-0.2% (May 20, 2026)
Weeks tracked32
Tracking sinceJan 14, 2026

Price History

1W

-0.1%

1M

-0.1%

3M

+0.1%

6M

-0.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FOCALIN XR 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FOCALIN XR 10 MG CAPSULE, manufactured by Sandoz Inc., is $4.7619 per EA (NDC 66758023631), effective Aug 19, 2026.

How has the price of FOCALIN XR 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FOCALIN XR 10 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 32 weekly CMS publications since Jan 14, 2026.

What are the highest and lowest recorded NADAC prices for FOCALIN XR 10 MG CAPSULE?

Since Jan 14, 2026, the NADAC for FOCALIN XR 10 MG CAPSULE has ranged from a low of $4.7590 (May 20, 2026) to a high of $4.7681 (May 13, 2026), with a median of $4.7681 per EA.

Are there cheaper alternatives to FOCALIN XR 10 MG CAPSULE?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 10 MG CP, is $1.5558 per EA — about 67% below FOCALIN XR 10 MG CAPSULE.

Who manufactures FOCALIN XR 10 MG CAPSULE?

FOCALIN XR 10 MG CAPSULE (NDC 66758023631) is labeled by Sandoz Inc., and CMS classifies it as a brand product.